Food Intake Response to Short-Term Modifications of Metabolism in Humans

NCT ID: NCT02939404

Last Updated: 2025-07-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-27

Study Completion Date

2024-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats.

Objectives:

To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.

Eligibility:

Healthy people ages 18-55.

Design:

Participants will stay at NIH for 20 days.

During the first 4 days, participants will have:

* Medical exam
* Electrocardiogram
* Blood and urine tests. One blood test includes drinking a sugar solution.
* DXA body composition scan
* Questions about foods they like, physical activity, and personal behavior
* Exercise test on a stationary bicycle

Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.

Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum).

Participants will have blood and urine collected.

Participants will swallow an ingestible wireless sensor and wear a small data recorder device.

On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.

Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More than 30% of adults are considered overweight. In general, lifestyle changes (diet and exercise) or current weight loss drugs only lead to about 5 to 10% weight loss. This may be because a person's energy expenditure, aka the number of calories the body uses, leads to hunger and may increase the amount of food a person eats. Cold exposure is known to increase metabolism but it may not lead to weight loss if appetite and the desire for food are also increased. The primary goal of this study is to evaluate whether changing energy expenditure by cool temperature exposure results in changes in food intake. This study will involve a stay on our clinical research unit where we will determine the energy requirements (at 24 degree C) of 68 healthy, adult volunteers without evidence of diabetes. Exposure to cool temperatures (19 degree C) will be used to increase the number of calories a person's body uses in a day. Participants will spend 24 hours in a room that measures energy expenditure while the temperature in the room is turned down, once with a fixed diet (eucaloric) and once with a buffet of food choices (ad libitum). After the fixed diet, volunteers will self-select how much food they wish to eat for one day from a vending machine. Volunteers will also spend one day fasting followed by a day self-selecting their food from the vending machine. Findings from this study will provide knowledge about a possible causal link between energy expenditure and eating behavior. This information may shed light on why many weight loss interventions that increase energy expenditure do not work as well as expected, and may eventually lead to new weight loss approaches and therapies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. Chamber at 24C, fixed diet

Chamber at room temperature (24C) with a fixed eucaloric diet

Group Type EXPERIMENTAL

Normal temperature

Intervention Type OTHER

23.25 hours inside respiratory chamber with the temperature set to 24°C

Fixed diet

Intervention Type OTHER

A diet that matches the participant's caloric needs

2. Chamber at 24C, ad libitum diet

Chamber at room temperature (24C) with an ad libitum diet (self-select how much food they wish to eat)

Group Type EXPERIMENTAL

Normal temperature

Intervention Type OTHER

23.25 hours inside respiratory chamber with the temperature set to 24°C

Ad libitum diet

Intervention Type OTHER

Participants can eat as much as they want

3. Chamber at 19C, fixed diet

Chamber at cold temperature (16C) with a fixed eucaloric diet

Group Type EXPERIMENTAL

Cold exposure

Intervention Type OTHER

23.25 hours inside respiratory chamber with the temperature set to19°C

Fixed diet

Intervention Type OTHER

A diet that matches the participant's caloric needs

4. Chamber at 19C, ad libitum diet

Chamber at cold temperature (19C) with an ad libitum diet (self-select how much food they wish to eat)

Group Type EXPERIMENTAL

Cold exposure

Intervention Type OTHER

23.25 hours inside respiratory chamber with the temperature set to19°C

Ad libitum diet

Intervention Type OTHER

Participants can eat as much as they want

5. Chamber at 24C, fasting

Chamber at room temperature (24C) fasting while in chamber and 12 hours before

Group Type EXPERIMENTAL

Normal temperature

Intervention Type OTHER

23.25 hours inside respiratory chamber with the temperature set to 24°C

Fasting

Intervention Type OTHER

Participants do not eat for 12 hours before and 24 hours in chamber

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cold exposure

23.25 hours inside respiratory chamber with the temperature set to19°C

Intervention Type OTHER

Normal temperature

23.25 hours inside respiratory chamber with the temperature set to 24°C

Intervention Type OTHER

Fixed diet

A diet that matches the participant's caloric needs

Intervention Type OTHER

Ad libitum diet

Participants can eat as much as they want

Intervention Type OTHER

Fasting

Participants do not eat for 12 hours before and 24 hours in chamber

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Eucaloric diet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Premenopausal women and men \<55 years of age
* Body weight \<204 kg (\<450 pounds) and \>= 36 kg (\>= 80 pounds)
* Stable weight (+/-5% within past 6 months) as determined by volunteer report
* Healthy, as determined by medical history, physical examination, and laboratory tests

Exclusion Criteria

* Age \<18 years
* Weight greater than or equal to 204 kg (greater than or equal to 450 pounds, maximum weight of the iDXA machine as per manufacturer s manual), or weight \<36 kg (\<80 pounds, minimum weight allowed based on the NIH guidelines of blood drawing for research purposes)
* Use of medications affecting metabolism and appetite in the last three months
* Expresses unwillingness to consume all food given during the weight maintaining diet portions of the study (e.g., due to strict dietary restrictions including allergies or vegetarian or kosher diet)
* Current use of tobacco products, marijuana, amphetamines, cocaine, or intravenous drug use
* Current pregnancy, pregnancy within the past 6 months or lactation
* History or clinical manifestation of:

* Type 1 and Type 2 diabetes mellitus
* History of surgery for the treatment of obesity
* Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo and hyperthyroidism
* Pulmonary disorders, including chronic obstructive pulmonary disease
* Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
* High blood pressure by sitting blood pressure measurement using an appropriate cuff higher than 140/90 mmHg on two or more occasions, or current antihypertensive therapy
* Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 2x normal
* Gastrointestinal disease including Crohn s disease, ulcerative colitis, celiac disease or other malabsorptive disorders
* Abnormal kidney function (eGFR \<60 mL/min/1.73m(2))
* Central nervous system disease, including previous history of cerebrovascular accidents, dementia, neurodegenerative disorders or history of severe head trauma
* Cancer requiring treatment in the past five years, except for nonmelanoma skin cancers or cancers that have clearly been cured
* Infectious disease such as active tuberculosis, HIV (by self report), chronic coccidiomycoses or other chronic infections that might influence EE and weight
* Diagnosis of binge eating disorder, anorexia and major psychiatric disorders based upon the DSM-IV including depression, schizophrenia and psychosis, which may impact the ability of the participant to be in the respiratory chamber for 24 hour time periods
* Chronic ethanol use (more than 3 drinks/day)
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Douglas Chang, M.D.

Role: PRINCIPAL_INVESTIGATOR

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NIDDK, Phoenix

Phoenix, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Unlu Y, Piaggi P, Stinson EJ, De Baca TC, Rodzevik TL, Walter M, Fry H, Krakoff J, Chang DC. Cold induces increased ad libitum energy intake independent of changes in energy expenditure: a controlled crossover trial in adults. Am J Clin Nutr. 2025 Feb;121(2):293-303. doi: 10.1016/j.ajcnut.2024.12.013. Epub 2024 Dec 14.

Reference Type DERIVED
PMID: 39675563 (View on PubMed)

Hollstein T, Heinitz S, Ando T, Rodzevik TL, Basolo A, Walter M, Chang DC, Krakoff J, Piaggi P. Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 Concentration. Diabetes. 2020 Jul;69(7):1382-1388. doi: 10.2337/db20-0153. Epub 2020 Apr 27.

Reference Type DERIVED
PMID: 32341039 (View on PubMed)

Hollstein T, Basolo A, Ando T, Votruba SB, Walter M, Krakoff J, Piaggi P. Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes. J Clin Endocrinol Metab. 2020 May 1;105(5):1375-92. doi: 10.1210/clinem/dgaa098.

Reference Type DERIVED
PMID: 32118268 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-DK-N004

Identifier Type: OTHER

Identifier Source: secondary_id

999917004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.